Comparing Oscar Health and UnitedHealth Group for 2026

Investors evaluating the healthcare sector in 2026 are weighing the potential of Oscar Health, a tech-focused challenger, against the established scale of UnitedHealth Group. While Oscar Health emphasizes digital engagement and agility in the individual insurance market, UnitedHealth operates as a massive, vertically integrated conglomerate serving approximately 151 million people [1].

Key takeaways

• Oscar Health reported FY 2025 revenue of approximately $11.7 billion, representing 27.5% growth, though it posted a net loss of nearly $443.2 million [1].
• UnitedHealth Group generated $447.6 billion in revenue in FY 2025, an 11.8% increase over the prior year, with a net income of $12.1 billion [1].
• UnitedHealth is currently navigating a transition period marked by leadership changes, regulatory hurdles, and an antitrust investigation [2, 3].
• Oscar Health faces significant risks related to its reliance on federal funding and the Affordable Care Act, with 93% of its premiums coming from the Centers for Medicare & Medicaid Services [1].

Divergent Business Models and Financial Profiles

Oscar Health functions as a "disruptor" in the U.S. individual coverage market, utilizing a tech-enabled platform that includes the Lucie Health Marketplace [1]. By early 2026, the company reached nearly 3.2 million members [1]. Despite its rapid revenue expansion, the company maintains a current ratio of approximately 0.9x, suggesting tighter short-term liquidity [1]. Its business model is highly concentrated, as nearly 93% of its premiums are derived from the Centers for Medicare & Medicaid Services, creating exposure to potential changes in federal funding and the Affordable Care Act [1].

In contrast, UnitedHealth Group is a diversified giant operating through its UnitedHealthcare insurance segment and its Optum health technology and clinical services division [1]. The company is currently working to improve margins after a challenging 2025, which saw its stock price finish the year down 33% [3]. To address rising program costs and margin pressures in its Medicare Advantage business, UnitedHealth reduced its membership in those plans by 1.3 million people in 2026 [2]. Recent financial results show signs of stabilization; in the first quarter of 2026, the company reported revenue of $111.7 billion and raised its full-year earnings per share guidance to a range of $17.35 to $18.25 [2, 3].

Why it matters

The choice between these two companies represents a fundamental decision between growth-oriented speculation and established market stability. Oscar Health offers the potential upside of a younger company focused on virtual care and digital member experiences, though it carries higher risks associated with its shorter track record and financial losses [1]. UnitedHealth, while facing significant regulatory and legal challenges—including allegations of fraud and denial of care—remains a dominant force in the industry [1, 2]. For long-term investors, UnitedHealth’s current valuation and its 2.3% dividend yield are cited as reasons to consider it a buy, while others may be drawn to the disruptive potential of Oscar Health despite the inherent volatility [1, 2].